Australia's Althea Group jumps on cannabis product approval in UK

Peak Processing

11/05/2023 03:54

** Shares of Australia's Althea Group Holdings Ltd  AGH.AX 
rise as much as 4.1% to A$0.051   
    ** Stock set to mark best day since April 26, if current
gains hold  
    ** Cannabis-based pharma co says UK public health system
National Health Service has approved Althea CBD10:THC5 for UK
patients
    ** Co says Althea CBD10:THC5 is used to treat patients with
chronic persistent pain       
    ** AGH has fallen 19.7% this year, as of last close

 (Reporting by Nausheen Thusoo in Bengaluru)
 ((Nausheen.Thusoo@thomsonreuters.com;))